APO Research

APO RESEARCH · REPORT

Avapritinib Tablets

Selected research

Industry Growth & Trends

Global Avapritinib Tablets Industry Growth and Trends Forecast to 2032

Market perspective

The global Avapritinib Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Avapritinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Avapritinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Avapritinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Avapritinib Tablets include Blueprint Medicines and CStone Pharmaceuticals among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Avapritinib Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Avapritinib Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Avapritinib Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Avapritinib Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Avapritinib Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Avapritinib Tablets Market by Company

Blueprint Medicines

CStone Pharmaceuticals

Avapritinib Tablets Segment by Type

100mg/pc

200mg/pc

300mg/pc

Others

Avapritinib Tablets Segment by Application

In-hospital Sales

Out-of-hospital Sales

Avapritinib Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Avapritinib Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Avapritinib Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Avapritinib Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Avapritinib Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Avapritinib Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 100mg/pc Table 2. Major Company of 200mg/pc Table 3. Major Company of 300mg/pc Table 4. Major Company of Others Table 5. Global Avapritinib Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Avapritinib Tablets Sales by Type (2021-2026) & (K Units) Table 7. Global Avapritinib Tablets Sales Market Share in Volume by Type (2021-2026) Table 8. Global Avapritinib Tablets Sales by Type (2021-2026) & (US$ Million) Table 9. Global Avapritinib Tablets Sales Market Share in Value by Type (2021-2026) Table 10. Global Avapritinib Tablets Price by Type (2021-2026) & (US$/Unit) Table 11. Global Avapritinib Tablets Sales by Type (2027-2032) & (K Units) Table 12. Global Avapritinib Tablets Sales Market Share in Volume by Type (2027-2032) Table 13. Global Avapritinib Tablets Sales by Type (2027-2032) & (US$ Million) Table 14. Global Avapritinib Tablets Sales Market Share in Value by Type (2027-2032) Table 15. Global Avapritinib Tablets Price by Type (2027-2032) & (US$/Unit) Table 16. North America Avapritinib Tablets Sales by Type (2021-2026) & (K Units) Table 17. North America Avapritinib Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Avapritinib Tablets Sales by Type (2021-2026) & (K Units) Table 19. Europe Avapritinib Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Avapritinib Tablets Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Avapritinib Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Avapritinib Tablets Sales by Type (2021-2026) & (K Units) Table 23. Latin America Avapritinib Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Avapritinib Tablets Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Avapritinib Tablets Sales by Type (2021-2026) & (US$ Million) Table 26. Avapritinib Tablets Industry Trends Table 27. Avapritinib Tablets Industry Drivers Table 28. Avapritinib Tablets Industry Opportunities and Challenges Table 29. Avapritinib Tablets Industry Restraints Table 30. Global Avapritinib Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Avapritinib Tablets Revenue Market Share by Company (2021-2026) Table 32. Global Avapritinib Tablets Sales by Company (2021-2026) & (K Units) Table 33. Global Avapritinib Tablets Sales Share by Company (2021-2026) Table 34. Global Avapritinib Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Avapritinib Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Avapritinib Tablets Major Company Production Sites and Headquarters Table 37. Global Avapritinib Tablets Company, Product Type & Application Table 38. Global Avapritinib Tablets Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Avapritinib Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Avapritinib Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Avapritinib Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Avapritinib Tablets Sales Market Share in Volume by Region (2021-2026) Table 44. Global Avapritinib Tablets Sales by Region (2021-2026) & (US$ Million) Table 45. Global Avapritinib Tablets Sales Market Share in Value by Region (2021-2026) Table 46. Global Avapritinib Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Avapritinib Tablets Sales by Region (2027-2032) & (K Units) Table 48. Global Avapritinib Tablets Sales Market Share in Volume by Region (2027-2032) Table 49. Global Avapritinib Tablets Sales by Region (2027-2032) & (US$ Million) Table 50. Global Avapritinib Tablets Sales Market Share in Value by Region (2027-2032) Table 51. Global Avapritinib Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Avapritinib Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Avapritinib Tablets Sales by Application (2021-2026) & (K Units) Table 54. Global Avapritinib Tablets Sales Market Share in Volume by Application (2021-2026) Table 55. Global Avapritinib Tablets Sales by Application (2021-2026) & (US$ Million) Table 56. Global Avapritinib Tablets Sales Market Share in Value by Application (2021-2026) Table 57. Global Avapritinib Tablets Price by Application (2021-2026) & (US$/Unit) Table 58. Global Avapritinib Tablets Sales by Application (2027-2032) & (K Units) Table 59. Global Avapritinib Tablets Sales Market Share in Volume by Application (2027-2032) Table 60. Global Avapritinib Tablets Sales by Application (2027-2032) & (US$ Million) Table 61. Global Avapritinib Tablets Sales Market Share in Value by Application (2027-2032) Table 62. Global Avapritinib Tablets Price by Application (2027-2032) & (US$/Unit) Table 63. North America Avapritinib Tablets Sales by Application (2021-2026) & (K Units) Table 64. North America Avapritinib Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Avapritinib Tablets Sales by Application (2021-2026) & (K Units) Table 66. Europe Avapritinib Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Avapritinib Tablets Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Avapritinib Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Avapritinib Tablets Sales by Application (2021-2026) & (K Units) Table 70. Latin America Avapritinib Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Avapritinib Tablets Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Avapritinib Tablets Sales by Application (2021-2026) & (US$ Million) Table 73. Blueprint Medicines Company Information Table 74. Blueprint Medicines Business Overview Table 75. Blueprint Medicines Avapritinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Blueprint Medicines Avapritinib Tablets Product Portfolio Table 77. Blueprint Medicines Recent Development Table 78. CStone Pharmaceuticals Company Information Table 79. CStone Pharmaceuticals Business Overview Table 80. CStone Pharmaceuticals Avapritinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. CStone Pharmaceuticals Avapritinib Tablets Product Portfolio Table 82. CStone Pharmaceuticals Recent Development Table 83. North America Avapritinib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 84. North America Avapritinib Tablets Sales by Country (2021-2026) & (K Units) Table 85. North America Avapritinib Tablets Sales Market Share by Country (2021-2026) Table 86. North America Avapritinib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 87. North America Avapritinib Tablets Sales Market Share Forecast by Country (2027-2032) Table 88. North America Avapritinib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. North America Avapritinib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 90. North America Avapritinib Tablets Market Share by Country (2021-2026) Table 91. North America Avapritinib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. North America Avapritinib Tablets Market Share Forecast by Country (2027-2032) Table 93. Europe Avapritinib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 94. Europe Avapritinib Tablets Sales by Country (2021-2026) & (K Units) Table 95. Europe Avapritinib Tablets Sales Market Share by Country (2021-2026) Table 96. Europe Avapritinib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 97. Europe Avapritinib Tablets Sales Market Share Forecast by Country (2027-2032) Table 98. Europe Avapritinib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Europe Avapritinib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 100. Europe Avapritinib Tablets Market Share by Country (2021-2026) Table 101. Europe Avapritinib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Europe Avapritinib Tablets Market Share Forecast by Country (2027-2032) Table 103. Asia-Pacific Avapritinib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 104. Asia-Pacific Avapritinib Tablets Sales by Country (2021-2026) & (K Units) Table 105. Asia-Pacific Avapritinib Tablets Sales Market Share by Country (2021-2026) Table 106. Asia-Pacific Avapritinib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 107. Asia-Pacific Avapritinib Tablets Sales Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Avapritinib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Avapritinib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific Avapritinib Tablets Market Share by Country (2021-2026) Table 111. Asia-Pacific Avapritinib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific Avapritinib Tablets Market Share Forecast by Country (2027-2032) Table 113. Latin America Avapritinib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 114. Latin America Avapritinib Tablets Sales by Country (2021-2026) & (K Units) Table 115. Latin America Avapritinib Tablets Sales Market Share by Country (2021-2026) Table 116. Latin America Avapritinib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 117. Latin America Avapritinib Tablets Sales Market Share Forecast by Country (2027-2032) Table 118. Latin America Avapritinib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Latin America Avapritinib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 120. Latin America Avapritinib Tablets Market Share by Country (2021-2026) Table 121. Latin America Avapritinib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Latin America Avapritinib Tablets Market Share Forecast by Country (2027-2032) Table 123. Middle East and Africa Avapritinib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. Middle East and Africa Avapritinib Tablets Sales by Country (2021-2026) & (K Units) Table 125. Middle East and Africa Avapritinib Tablets Sales Market Share by Country (2021-2026) Table 126. Middle East and Africa Avapritinib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 127. Middle East and Africa Avapritinib Tablets Sales Market Share Forecast by Country (2027-2032) Table 128. Middle East and Africa Avapritinib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Middle East and Africa Avapritinib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 130. Middle East and Africa Avapritinib Tablets Market Share by Country (2021-2026) Table 131. Middle East and Africa Avapritinib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Avapritinib Tablets Market Share Forecast by Country (2027-2032) Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Avapritinib Tablets Distributors List Table 136. Avapritinib Tablets Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Avapritinib Tablets Image Figure 2. Global Avapritinib Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Avapritinib Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Avapritinib Tablets Sales (2021-2032) & (K Units) Figure 5. 100mg/pc Image Figure 6. Global 100mg/pc Sales YoY Growth (2021-2032) & (K Units) Figure 7. 200mg/pc Image Figure 8. Global 200mg/pc Sales YoY Growth (2021-2032) & (K Units) Figure 9. 300mg/pc Image Figure 10. Global 300mg/pc Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Avapritinib Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Avapritinib Tablets Market Share by Type 2025 VS 2032 Figure 15. North America Avapritinib Tablets Sales Market Share in Volume by Type in 2025 Figure 16. North America Avapritinib Tablets Sales Market Share in Value by Type in 2025 Figure 17. Europe Avapritinib Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Europe Avapritinib Tablets Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Avapritinib Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Avapritinib Tablets Sales Market Share in Value by Type in 2025 Figure 21. Latin America Avapritinib Tablets Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Avapritinib Tablets Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Avapritinib Tablets Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Avapritinib Tablets Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Avapritinib Tablets Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. In-hospital Sales Image Figure 28. Global In-hospital Sales Sales YoY Growth (2021-2032) & (K Units) Figure 29. Out-of-hospital Sales Image Figure 30. Global Out-of-hospital Sales Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Avapritinib Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Avapritinib Tablets Market Share by Application 2025 VS 2032 Figure 33. North America Avapritinib Tablets Sales Market Share in Volume by Application in 2025 Figure 34. North America Avapritinib Tablets Sales Market Share in Value by Application in 2025 Figure 35. Europe Avapritinib Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Europe Avapritinib Tablets Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Avapritinib Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Avapritinib Tablets Sales Market Share in Value by Application in 2025 Figure 39. Latin America Avapritinib Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Avapritinib Tablets Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Avapritinib Tablets Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Avapritinib Tablets Sales Market Share in Value by Application in 2025 Figure 43. North America Avapritinib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Avapritinib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Avapritinib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Avapritinib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Avapritinib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Avapritinib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Avapritinib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Avapritinib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Avapritinib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Avapritinib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Avapritinib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Avapritinib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Avapritinib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Avapritinib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Avapritinib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Avapritinib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Avapritinib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Avapritinib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Avapritinib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Avapritinib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Avapritinib Tablets Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Avapritinib Tablets Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg/pc
  • 200mg/pc
  • 300mg/pc
  • Others
Applications
  • In-hospital Sales
  • Out-of-hospital Sales
Companies covered
  • Blueprint Medicines
  • CStone Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Avapritinib Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Avapritinib Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Avapritinib Tablets Market by Type
  6. 1.3.1 100mg/pc
  7. 1.3.2 200mg/pc
  8. 1.3.3 300mg/pc
  9. 1.3.4 Others
  10. 1.4 Global Avapritinib Tablets Market Size by Type
  11. 1.4.1 Global Avapritinib Tablets Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Avapritinib Tablets Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Avapritinib Tablets Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Avapritinib Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Avapritinib Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Avapritinib Tablets Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Avapritinib Tablets Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Avapritinib Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Avapritinib Tablets Industry Trends
  2. 2.2 Avapritinib Tablets Industry Drivers
  3. 2.3 Avapritinib Tablets Industry Opportunities and Challenges
  4. 2.4 Avapritinib Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Avapritinib Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Avapritinib Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Avapritinib Tablets Price (2021-2026)
  4. 3.4 Global Avapritinib Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Avapritinib Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Avapritinib Tablets Company, Product Type & Application
  7. 3.7 Global Avapritinib Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Avapritinib Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Avapritinib Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Avapritinib Tablets Tier 1, Tier 2, and Tier 3
4 Avapritinib Tablets Regional Status and Outlook
  1. 4.1 Global Avapritinib Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Avapritinib Tablets Historic Market Size by Region
  3. 4.2.1 Global Avapritinib Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Avapritinib Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Avapritinib Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Avapritinib Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Avapritinib Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Avapritinib Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Avapritinib Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Avapritinib Tablets by Application
  1. 5.1 Avapritinib Tablets Market by Application
  2. 5.1.1 In-hospital Sales
  3. 5.1.2 Out-of-hospital Sales
  4. 5.2 Global Avapritinib Tablets Market Size by Application
  5. 5.2.1 Global Avapritinib Tablets Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Avapritinib Tablets Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Avapritinib Tablets Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Avapritinib Tablets Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Avapritinib Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Avapritinib Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Avapritinib Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Avapritinib Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Blueprint Medicines
  2. 6.1.1 Blueprint Medicines Company Information
  3. 6.1.2 Blueprint Medicines Business Overview
  4. 6.1.3 Blueprint Medicines Avapritinib Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Blueprint Medicines Avapritinib Tablets Product Portfolio
  6. 6.1.5 Blueprint Medicines Recent Developments
  7. 6.2 CStone Pharmaceuticals
  8. 6.2.1 CStone Pharmaceuticals Company Information
  9. 6.2.2 CStone Pharmaceuticals Business Overview
  10. 6.2.3 CStone Pharmaceuticals Avapritinib Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CStone Pharmaceuticals Avapritinib Tablets Product Portfolio
  12. 6.2.5 CStone Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Avapritinib Tablets Sales by Country
  2. 7.1.1 North America Avapritinib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Avapritinib Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Avapritinib Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Avapritinib Tablets Market Size by Country
  6. 7.2.1 North America Avapritinib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Avapritinib Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Avapritinib Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Avapritinib Tablets Sales by Country
  2. 8.1.1 Europe Avapritinib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Avapritinib Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Avapritinib Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Avapritinib Tablets Market Size by Country
  6. 8.2.1 Europe Avapritinib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Avapritinib Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Avapritinib Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Avapritinib Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Avapritinib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Avapritinib Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Avapritinib Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Avapritinib Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Avapritinib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Avapritinib Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Avapritinib Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Avapritinib Tablets Sales by Country
  2. 10.1.1 South America Avapritinib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Avapritinib Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Avapritinib Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Avapritinib Tablets Market Size by Country
  6. 10.2.1 South America Avapritinib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Avapritinib Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Avapritinib Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Avapritinib Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Avapritinib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Avapritinib Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Avapritinib Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Avapritinib Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Avapritinib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Avapritinib Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Avapritinib Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Avapritinib Tablets Value Chain Analysis
  2. 12.1.1 Avapritinib Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Avapritinib Tablets Production Mode & Process
  7. 12.2 Avapritinib Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Avapritinib Tablets Distributors
  10. 12.2.3 Avapritinib Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research